Search

A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease

Trial Phase 1 Recruiting Sept. 11, 2025

A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment

Trial Phase 2 Completed Sept. 11, 2025

Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease

Trial Phase 1 Completed Sept. 11, 2025

Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

Trial N/A Recruiting Sept. 11, 2025

Bilateral Putaminal Convection of Adeno-Associated Virus Vector Serotype 2 Glial Cell Line-Derived Neurotrophic Factor Gene Therapy in Parkinson's Disease May Provide Glial Cell Line-Derived Neurotrophic Factor Transgene Expression to Caudate Nucleus: Potential Role of Perivascular and Other Low Resistance Leakage Pathways.

Research Neurosurgery Sept. 11, 2025

Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease

Trial Phase 1 Enrolling by invitation Sept. 10, 2025

The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease

Trial Phase 1 Recruiting Sept. 10, 2025

Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease

Trial Phase 2 Recruiting Sept. 9, 2025

The Effects of Scapulohumeral Rehabilitation on Scapula Kinematics and Upper Extremity Functionality in Individuals With Parkinson's Disease

Trial N/A Active, not recruiting Sept. 9, 2025

Comparing Antipsychotic Medications in LBD Over Time

Trial Phase 4 Recruiting Sept. 8, 2025

Parkinson's Disease Progression Study

Trial N/A Active, not recruiting Sept. 8, 2025

Prolactin, Inflammation, and Parkinson's Severity

Trial N/A Enrolling by invitation Sept. 8, 2025

Gait Re-education Program in Subjects With Parkinson´s Disease

Trial N/A Completed Sept. 8, 2025

DBS of the MLR for Gait and Balance Disorders in PD Patients

Trial N/A Completed Sept. 7, 2025

A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

Trial Phase 1 Completed Sept. 4, 2025

Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease

Trial Phase 1 Recruiting Sept. 4, 2025

Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease

Trial N/A Completed Sept. 4, 2025

The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes

Trial Phase 2 Recruiting Sept. 4, 2025

Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD

Trial N/A Recruiting Sept. 3, 2025

Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status

Trial N/A Active, not recruiting Sept. 3, 2025